SCHEMBL25412295

SCHEMBL25412295

CCNc1cc(C2(c3nnc(S)n3C)CC(C)C2)nc(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30598901 1.00 — —
SCHEMBL25413303 0.84 CBLB (0.38) —
SCHEMBL30598910 0.84 CBLB (0.38) —
SCHEMBL25414185 0.72 CBLB (0.33) —
SCHEMBL25413065 0.69 HCAR3 (0.36) —
SCHEMBL30184943 0.68 CBLB (0.37) —
SCHEMBL25414247 0.68 HCAR3 (0.32) —
SCHEMBL25413551 0.67 CBLB (0.44) —
SCHEMBL25413553 0.67 CBLB (0.44) —
SCHEMBL30872125 0.66 CBLB (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304563-A1 ACTIVATORS OF EFFECTOR T CELLS ORUM THERAPEUTICS, INC. (KR) 2025-10-02 — — US disclosed
WO-2023170608-A1 ACTIVATORS OF EFFECTOR T CELLS ORUM THERAPEUTICS, INC. (KR) 2023-09-14 — — WO disclosed
WO-2023170608-A1 ACTIVATORS OF EFFECTOR T CELLS ORUM THERAPEUTICS, INC. (KR) 2023-09-14 — — WO disclosed
Send feedback